| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415673A1 Tetrazole derivatives |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415392A1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2414783A1 Treatment of eating disorders using carboxyalkylethers |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414407A1 Stabilized 1.alpha.-hydroxy vitamin d |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/23/2002 | EP1174426A1 Method for the preparation of tricyclic amino alcohol derivatives through azides |
| 01/23/2002 | EP1174416A1 Conjugated fatty acid esters |
| 01/23/2002 | EP1174146A1 Agents for ameliorating pancreatic function disorder |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1174109A2 Combinations of active substances respectively adducts from cyclodextrins and at least a quinone and/or at least a hydroquinone and use of such combinations of active substances in cosmetic preparations |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173757A1 Diagnosis of human kidney diseases |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173482A1 Insulin crystals for pulmonary administration |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173464A2 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173438A1 Substituted imidazoles, their preparation and use |
| 01/23/2002 | EP1173437A2 Thiazolidinedione derivative and its use as antidiabetic |
| 01/23/2002 | EP1173436A2 Thiazolidinedione derivative and its use as antidiabetic |
| 01/23/2002 | EP1173435A1 Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 01/23/2002 | EP1173434A2 Thiazolidinedione derivative and its use as antidiabetic |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173408A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 01/23/2002 | EP1173215A1 Over-coated chewing gum formulations |
| 01/23/2002 | EP1173205A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 01/23/2002 | EP1173188A2 Pharmaceutical composition comprising an inositol and a metal ion for improving insulin sensitivity and glucose metabolism |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 01/23/2002 | EP1173172A1 Synergistic effects of amlodipine and atorvastatin |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173168A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 01/23/2002 | EP1173165A1 Cardiovascular and bone treatment using isoflavones |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP1173149A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract |
| 01/23/2002 | EP1173071A1 Ginseng berry health products |
| 01/23/2002 | EP1173070A1 Cactus fruit health products |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP1025100B1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 01/23/2002 | EP0941103B1 Pharmaceutical composition for treatment of diabetes |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0846693B1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| 01/23/2002 | EP0755258B1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/23/2002 | EP0726771B1 Desferrioxamine oral delivery system |
| 01/23/2002 | CN1332849A Methods and compositions to lower plasma cholesterol levels |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332638A Combination comprising beta-agonist and further antidiabetic agent |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332631A Composition and method for increasing weight gain and feed efficiency |
| 01/23/2002 | CN1332627A Method of producing vitamin powder |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1331997A Antilpemic and thrombolytic pill |
| 01/23/2002 | CN1331994A Chinese medicine for treating diabetic neural lesion |
| 01/23/2002 | CN1331993A Hypoglycemic deep-rooted ulcer eliminating medicine |
| 01/23/2002 | CN1331990A Chinese medicine for treating diabetes |
| 01/23/2002 | CN1331987A Active Chinese medicine targeting essence and its prepn |
| 01/23/2002 | CN1331979A Bromhidrosis treating composite Chinese medicine and its dosage |
| 01/23/2002 | CN1331975A Prepn of composite calcium replenishing liquid |
| 01/23/2002 | CN1331972A Medicine for preventing and treating white bottom disease of turtle |
| 01/23/2002 | CN1331920A Oral composition with cardiovascular health and senility delaying functions |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340683 Selective NPY (Y5) antagonists (triazines) |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340669 Lipoprotein complexes and compositions containing them |
| 01/22/2002 | CA2214872C Benzothiophene compounds, compositions and methods |
| 01/22/2002 | CA2093794C 1'-aminospiro¬isoquinoline-4(1h),3-pyrrolidine|-1,2',3,5'-(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 01/22/2002 | CA2028909C Preparation of intermediates and the synthesis of n-(2-hydroxy-ethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidines |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004616A1 RECOMBINANT α-L-IDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004515A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | WO2002004474A1 Adenosine compound and pharmaceutical composition containing the same |
| 01/17/2002 | WO2002004472A1 Novel compounds and methods |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004437A1 Obesity inhibitory materials |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004433A2 Melanin concentrating hormone receptor ligands |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |